Clinical Neuroscience

Our client collaborations have been enhancing clinical practice and treatment of neurological and psychiatric disorders for decades, positively impacting human health, public policy and the testing of innovative therapeutic solutions.

Our Phase I-IV clinical trial research services can advance your neuroscience research program, from protocol development to regulatory submissions and publications, and we offer particular expertise in Alzheimer’s disease, multiple sclerosis, epilepsy, traumatic brain injury, stroke, major depression and substance use as well as rare neurological diseases like Duchenne Muscular Dystrophy, Primary Mitochondrial Myopathy, and Angelman Syndrome.

You can recruit necessary sites and patients using our global site and patient access capability, while our expert biostatisticians and clinicians can maximise insights from your clinical trial by incorporating validated neuropsychological and quality of life (QOL) assessments in your study design.